Alyeska Investment Group, L.P. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 33 filers reported holding VASCULAR BIOGENICS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2020$107,000
-4.5%
83,3330.0%0.00%0.0%
Q1 2020$112,000
+12.0%
83,3330.0%0.00%
+100.0%
Q4 2019$100,000
-10.7%
83,3330.0%0.00%
-50.0%
Q3 2019$112,000
+3.7%
83,3330.0%0.00%
+100.0%
Q2 2019$108,000
-15.0%
83,3330.0%0.00%
-50.0%
Q1 2019$127,000
+56.8%
83,3330.0%0.00%
+100.0%
Q4 2018$81,000
-40.0%
83,3330.0%0.00%0.0%
Q3 2018$135,000
-26.2%
83,3330.0%0.00%
-50.0%
Q2 2018$183,000
-4.7%
83,3330.0%0.00%0.0%
Q1 2018$192,000
-67.6%
83,3330.0%0.00%
-60.0%
Q4 2017$592,000
+16.5%
83,3330.0%0.01%
+25.0%
Q3 2017$508,000
+36.9%
83,3330.0%0.00%
+33.3%
Q2 2017$371,000
-19.0%
83,3330.0%0.00%
-25.0%
Q1 2017$458,000
+13.4%
83,3330.0%0.00%
+33.3%
Q4 2016$404,000
-7.1%
83,3330.0%0.00%
-25.0%
Q3 2016$435,000
+13.3%
83,3330.0%0.00%0.0%
Q2 2016$384,000
+32.4%
83,3330.0%0.00%
+33.3%
Q1 2016$290,000
-33.8%
83,3330.0%0.00%
-40.0%
Q4 2015$438,00083,3330.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$5,751,0000.66%
Ikarian Capital, LLC 830,007$1,337,0000.24%
Telemetry Investments, L.L.C. 118,000$190,0000.22%
Urban Wealth Management, LLC 12,018$19,0000.06%
DLD Asset Management, LP 337,300$541,0000.04%
Phoenix Holdings Ltd. 513,597$827,0000.02%
Caption Management, LLC 140,000$225,0000.00%
HBK Sorce Advisory LLC 22,000$35,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$128,0000.00%
Total Clarity Wealth Management, Inc. 4,000$6,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders